← All Eupraxia Pharmaceuticals INC filings

Eupraxia Pharmaceuticals INC F-1 registration statements

The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.

NASDAQ
EPRX
Eupraxia Pharmaceuticals INC
F-10/A: Eupraxia Pharmaceuticals Files for US$200 Million Shelf Prospectus, Aims for Nasdaq Listing
Eupraxia Pharmaceuticals intends to offer up to US$200 million in various securities, including common shares, preferred shares, and debt securities, with plans to list its common shares on the Nasdaq Capital Market.
NASDAQ
EPRX
Eupraxia Pharmaceuticals INC
F-10: Eupraxia Pharmaceuticals Files for US$200 Million Shelf Prospectus, Aims for Nasdaq Listing
Eupraxia Pharmaceuticals files a preliminary short form base shelf prospectus for up to US$200 million in securities, seeking to list its common shares on the Nasdaq Capital Market.